BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 29191057)

  • 1. Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy.
    Qi SS; Sun JH; Yu HH; Yu SQ
    Drug Deliv; 2017 Nov; 24(1):1909-1926. PubMed ID: 29191057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review.
    Li B; Shao H; Gao L; Li H; Sheng H; Zhu L
    Drug Deliv; 2022 Dec; 29(1):2130-2161. PubMed ID: 35815678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology Assisted Chemotherapy for Targeted Cancer Treatment: Recent Advances and Clinical Perspectives.
    Lan HR; Wu ZQ; Zhang LH; Jin KT; Wang SB
    Curr Top Med Chem; 2020; 20(27):2442-2458. PubMed ID: 32703133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery.
    Amreddy N; Babu A; Muralidharan R; Panneerselvam J; Srivastava A; Ahmed R; Mehta M; Munshi A; Ramesh R
    Adv Cancer Res; 2018; 137():115-170. PubMed ID: 29405974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of nanotechnology for the treatment of cancer: Recent advances.
    Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
    Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
    Chen JN; Shen Q; Li SS
    Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
    Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
    Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanodrugs based on co-delivery strategies to combat cisplatin resistance.
    Wang Q; Li H; Wu T; Yu B; Cong H; Shen Y
    J Control Release; 2024 Jun; 370():14-42. PubMed ID: 38615892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mini-Review on Nano Technology in the Tumour Targeting Strategies: Drug Delivery to Cancer Cells.
    Kaur L; Sohal HS; Kaur M; Malhi DS; Garg S
    Anticancer Agents Med Chem; 2020; 20(17):2012-2024. PubMed ID: 32753024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
    Ho BN; Pfeffer CM; Singh ATK
    Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology applied to overcome tumor drug resistance.
    Gao Z; Zhang L; Sun Y
    J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanometric gold in cancer nanotechnology: current status and future prospect.
    Ahmad MZ; Akhter S; Rahman Z; Akhter S; Anwar M; Mallik N; Ahmad FJ
    J Pharm Pharmacol; 2013 May; 65(5):634-51. PubMed ID: 23600380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
    Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
    Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects.
    Li Y; Thambi T; Lee DS
    Adv Healthc Mater; 2018 Jan; 7(1):. PubMed ID: 28941203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart Drug-Delivery Systems for Cancer Nanotherapy.
    Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
    Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology for Cancer Therapy Based on Chemotherapy.
    Zhao CY; Cheng R; Yang Z; Tian ZM
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29617302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revolutionizing technologies of nanomicelles for combinatorial anticancer drug delivery.
    Jo MJ; Jin IS; Park CW; Hwang BY; Chung YB; Kim JS; Shin DH
    Arch Pharm Res; 2020 Jan; 43(1):100-109. PubMed ID: 31989478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.